North America Transdermal Drug Delivery System Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Type (Transdermal Patches, Transdermal Gel, Transdermal Sprays, and Others), Application (Cardiovascular Diseases, Central Nervous System Disorders, Pain Management, Hormonal Applications, and Other Applications), and Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)

No. of Pages: 109    |    Report Code: TIPRE00013277    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Transdermal Drug Delivery System Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Transdermal Drug Delivery System Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Transdermal Drug Delivery System Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Introduction of advanced transdermal drug delivery systems to boost their global uptake
5.2 Market Opportunities
  • 5.2.1 Advantages associated with a noninvasive drug delivery facilitated by transdermal drug delivery systems to drive the market growth
5.3 Future Trends
  • 5.3.1 Adoption of 3D printing technology and smart patches is likely to offer opportunities to the transdermal drug delivery systems market
5.4 Impact of Drivers and Restraints

6. North America Transdermal Drug Delivery System Market Regional Analysis

6.1 North America Transdermal Drug Delivery System Market Overview
6.2 North America Transdermal Drug Delivery System Market Revenue 2020-2030 (US$ Million)
6.3 North America Transdermal Drug Delivery System Market Forecast Analysis

7. North America Transdermal Drug Delivery System Market Analysis – by Type

7.1 Transdermal Patches
  • 7.1.1 Overview
  • 7.1.2 Transdermal Patches: North America Transdermal Drug Delivery System Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Transdermal Gel
  • 7.2.1 Overview
  • 7.2.2 Transdermal Gel: North America Transdermal Drug Delivery System Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Transdermal Sprays
  • 7.3.1 Overview
  • 7.3.2 Transdermal Sprays: North America Transdermal Drug Delivery System Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Transdermal Drug Delivery System Market Analysis – by Application

8.1 Cardiovascular Diseases
  • 8.1.1 Overview
  • 8.1.2 Cardiovascular Diseases: North America Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Central Nervous System Disorders
  • 8.2.1 Overview
  • 8.2.2 Central Nervous System Disorders: North America Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Pain Management
  • 8.3.1 Overview
  • 8.3.2 Pain Management: North America Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Hormonal Applications
  • 8.4.1 Overview
  • 8.4.2 Hormonal Applications: North America Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Other Applications
  • 8.5.1 Overview
  • 8.5.2 Other Applications: North America Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Transdermal Drug Delivery System Market Analysis – by Distribution Channel

9.1 Hospitals Pharmacies
  • 9.1.1 Overview
  • 9.1.2 Other Applications: North America Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Retail Pharmacies
  • 9.2.1 Overview
  • 9.2.2 Other Applications: North America Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Online Pharmacies
  • 9.3.1 Overview
  • 9.3.2 Other Applications: North America Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)

10. North America Transdermal Drug Delivery System Market – North America Analysis

10.1 North America
  • 10.1.1 North America Transdermal Drug Delivery System Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 North America Transdermal Drug Delivery System Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 US: North America Transdermal Drug Delivery System Market Breakdown, by Type
    • 10.1.1.1.2 US: North America Transdermal Drug Delivery System Market Breakdown, by Application
    • 10.1.1.1.3 US: North America Transdermal Drug Delivery System Market Breakdown, by Distribution Channel
  • 10.1.1.2 Canada: North America Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Canada: North America Transdermal Drug Delivery System Market Breakdown, by Type
    • 10.1.1.2.2 Canada: North America Transdermal Drug Delivery System Market Breakdown, by Application
    • 10.1.1.2.3 Canada: North America Transdermal Drug Delivery System Market Breakdown, by Distribution Channel
  • 10.1.1.3 Mexico : North America Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Transdermal Drug Delivery System Market Breakdown, by Type
    • 10.1.1.3.2 Mexico : North America Transdermal Drug Delivery System Market Breakdown, by Application
    • 10.1.1.3.3 Mexico : North America Transdermal Drug Delivery System Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Transdermal Drug Delivery System Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Boehringer Ingelheim International GmbH
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 GSK Plc
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Hisamitsu Pharmaceutical Co Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Johnson & Johnson
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Lavipharm SA
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Luye Pharma Group Ltd
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Novartis AG
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Purdue Pharma LP
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 UCB SA
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Viatris Inc
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Transdermal Drug Delivery System Market

1. Boehringer Ingelheim International GmbH 
2. GSK Plc 
3. Hisamitsu Pharmaceutical Co Inc 
4. Johnson & Johnson 
5. Lavipharm SA 
6. Luye Pharma Group Ltd 
7. Novartis AG 
8. Purdue Pharma LP 
9. UCB SA 
10. Viatris Inc 

north-america-transdermal-drug-delivery-system-market